Virtus LifeSci Biotech Products ETF Rating $105.92 -2.79 (-2.57%) As of 08/28/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort Interest Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.63Holdings in BBP have an aggregate rating of Moderate Buy based on 361 analyst ratings issued in the past year covering 25 companies (44.7% of the portfolio).BBP Aggregate Price Target$105.92High Prediction$105.92Average Prediction$105.92Low Prediction$105.92Holdings in BBP have an aggregate price target of $105.92 and a range of $105.92 to $105.92 covering 25 companies (44.7% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.13%CRNXCrinetics Pharmaceuticals$84.840.0%1.6588 of 5 stars2.24$81.00 -4.5%17Positive News2.51%OMEROmeros$18.61-3.3%4.0809 of 5 stars2.67$38.00 104.2%6Insider Trade2.18%IOVAIovance Biotherapeutics$8.01-3.0%1.8526 of 5 stars2.45$8.89 11.0%11Trending NewsAnalyst Revision2.05%VSTMVerastem$7.22-2.2%3.4134 of 5 stars2.80$13.83 91.6%10Positive News1.94%ZLABZai Lab$26.08-2.8%2.8044 of 5 stars2.71$37.25 42.8%71.89%KNSAKiniksa Pharmaceuticals International$78.08-2.2%3.8582 of 5 stars2.80$87.38 11.9%10Positive News1.81%HALOHalozyme Therapeutics$105.35-1.5%3.8575 of 5 stars2.62$91.20 -13.4%13News CoveragePositive News1.80%PTGXProtagonist Therapeutics$144.33-3.5%1.5912 of 5 stars2.94$140.53 -2.6%18News CoveragePositive News1.75%PGENPrecigen$6.95-3.3%3.884 of 5 stars2.80$14.50 108.6%5News CoverageInsider Trade1.71%ACADACADIA Pharmaceuticals$29.11-2.1%4.6799 of 5 stars2.78$34.36 18.0%18Positive NewsAnalyst Forecast1.68%REGNRegeneron Pharmaceuticals$794.19-1.7%4.3068 of 5 stars2.60$800.36 0.8%25Trending News1.68%ONCBeOne Medicines$366.73-1.5%3.578 of 5 stars3.00$402.14 9.7%17Insider Trade1.67%RYTMRhythm Pharmaceuticals$107.17-4.8%2.8725 of 5 stars2.74$141.12 31.7%19Positive NewsAnalyst ForecastGap Down1.65%RIGLRigel Pharmaceuticals$46.48-0.8%4.5424 of 5 stars2.43$59.00 26.9%7Positive NewsAnalyst Downgrade1.63%GERNGeron$1.51-1.3%2.2414 of 5 stars2.20$4.00 164.9%51.62%MRNAModerna$137.99-3.3%1.4847 of 5 stars2.17$80.53 -41.6%23Trending NewsAnalyst UpgradeGap Up1.62%XERSXeris Biopharma$8.48-1.4%4.0356 of 5 stars2.33$12.00 41.5%6News CoveragePositive News1.61%NUVBNuvation Bio$6.70-4.1%3.705 of 5 stars2.69$13.00 94.0%13Gap Up1.61%INSMInsmed$118.54-2.3%3.37 of 5 stars3.00$205.52 73.4%251.54%BMRNBioMarin Pharmaceutical$64.67-0.9%4.9084 of 5 stars2.75$88.79 37.3%24News CoveragePositive NewsAnalyst Forecast1.54%ROIVRoivant Sciences$34.71-7.6%2.0173 of 5 stars2.85$35.14 1.2%13Trending NewsAnalyst Forecast1.53%KURAKura Oncology$12.66-3.9%3.9153 of 5 stars2.69$25.40 100.6%131.53%BBIOBridgeBio Pharma$76.60-2.6%3.4551 of 5 stars2.83$100.79 31.6%231.52%TVTXTravere Therapeutics$65.67-2.7%1.7136 of 5 stars2.69$61.67 -6.1%13News CoveragePositive News1.51%SRPTSarepta Therapeutics$20.86-3.4%3.3957 of 5 stars2.20$25.06 20.1%20News CoveragePositive News This page (NYSEARCA:BBP) was last updated on 8/30/2026 by MarketBeat.com Staff. From Our PartnersA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredBuy These Stocks Before August 31stKeith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...TradeSmith | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredLook at this $5 stock’s addressA small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, ...Freedom Financial | SponsoredA Worldwide Gold Lockdown Is Now UnderwayGold has spiked above $4,400 an ounce as central bankers stockpile at one of the fastest paces in decades, acc...Stansberry Research | SponsoredIran War: What Happened at 1:11 P.M. Outside D.C.?A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...Banyan Hill Publishing | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
